ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 39 filers reported holding ACORDA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $28,747,000 | -0.7% | 36,500,000 | +7.4% | 0.62% | +5.6% |
| Q2 2019 | $28,947,000 | +5.2% | 34,000,000 | +9.7% | 0.59% | -11.3% |
| Q1 2019 | $27,517,000 | +15.5% | 31,000,000 | +7.7% | 0.66% | +18.0% |
| Q4 2018 | $23,830,000 | -2.5% | 28,775,000 | 0.0% | 0.56% | +69.3% |
| Q3 2018 | $24,434,000 | -12.1% | 28,775,000 | 0.0% | 0.33% | +7.4% |
| Q2 2018 | $27,809,000 | +6.3% | 28,775,000 | 0.0% | 0.31% | +17.0% |
| Q1 2018 | $26,153,000 | +7.3% | 28,775,000 | 0.0% | 0.26% | -24.8% |
| Q4 2017 | $24,369,000 | -6.9% | 28,775,000 | -0.8% | 0.35% | -10.2% |
| Q3 2017 | $26,173,000 | +5.2% | 29,000,000 | 0.0% | 0.39% | -4.9% |
| Q2 2017 | $24,886,000 | +39.6% | 29,000,000 | +38.3% | 0.41% | -6.8% |
| Q1 2017 | $17,829,000 | – | 20,975,000 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 15,510,000 | $16,119,000 | 3.21% |
| GRACE BROTHERS MANAGEMENT LLC | 2,500,000 | $2,592,000 | 2.44% |
| Mohican Financial Management, LLC | 3,000,000 | $3,113,000 | 1.52% |
| Wellesley Asset Management | 20,902 | $21,872,000 | 1.36% |
| Fore Research & Management, LP | 31,595,000 | $32,937,000 | 0.97% |
| Man Investments (CH) AG | 1,700,000 | $1,787,000 | 0.93% |
| SYMPHONY ASSET MANAGEMENT LLC | 7,834,000 | $8,128,000 | 0.84% |
| BASSO CAPITAL MANAGEMENT, L.P. | 5,000,000 | $5,150,000 | 0.79% |
| Baker Brothers Advisors | 60,000,000 | $62,050,000 | 0.78% |
| CAMDEN ASSET MANAGEMENT L P /CA | 10,225,000 | $10,608,000 | 0.44% |